Literature DB >> 19110794

Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry.

Alois Suessenbacher1, Jakob Doerler, Hannes Alber, Josef Aichinger, Johann Altenberger, Werner Benzer, Guenter Christ, Sebastian Globits, Kurt Huber, Ronald Karnik, Georg Norman, Peter Siostrzonek, Gerald Zenker, Otmar Pachinger, Franz Weidinger.   

Abstract

AIMS: Whether or not primary percutaneous coronary intervention (P-PCI) is equally effective and safe in women and men in a real world setting is still a matter of debate. The aim of this study was to evaluate the effect of gender on in-hospital outcome after P-PCI for ST-elevation myocardial infarction (STEMI) in a prospective national registry. METHODS AND
RESULTS: This registry includes in-hospital outcome data from 19 PCI-performing hospitals. During 12 months, 1087 patients with STEMI were registered (mean age 62 +/- 13 years; 27% women). Women were older than men (67 +/- 13 vs. 60 +/- 13 years; p < 0.001) and more often had diabetes mellitus (21% vs. 13%; p < 0.001) or cardiogenic shock (15% vs. 9%; p=0.004). PCI was performed in 1004 patients (92.4%) and more frequently in men than in women (93.9 vs. 88.3%, p=0.002), whereas conservative treatment was more often decided in women (9.3% vs 4.3%; p=0.002). No differences were found between women and men in primary success rate (TIMI 2+3 flow, 92.9% vs. 93%; p=0.96). On univariate analysis, in-hospital mortality was higher in women than in men (13.7% vs. 7.2%; p=0.001). On multivariable analysis age, shock, diabetes and TIMI flow before PCI remained associated with mortality.
CONCLUSIONS: Women have higher in-hospital mortality following PCI for STEMI. On multivariate analysis age, shock, diabetes and TIMI flow, but not gender, were associated with mortality in this national register. Older age and more comorbidity are likely to explain the higher mortality in female patients undergoing P-PCI.

Entities:  

Mesh:

Year:  2008        PMID: 19110794     DOI: 10.4244/eijv4i2a47

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  9 in total

1.  Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007.

Authors:  Jakob Dörler; Hannes Franz Alber; Johann Altenberger; Gerhard Bonner; Werner Benzer; Georg Grimm; Kurt Huber; Lalit Kaltenbach; Karl-Peter Pfeiffer; Herwig Schuchlenz; Peter Siostrzonek; Gerald Zenker; Otmar Pachinger; Franz Weidinger
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

Review 2.  [STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?].

Authors:  Alois Suessenbacher; Maria M Wanitschek; Jakob Doerler; Otmar Pachinger; Hannes F Alber
Journal:  Wien Med Wochenschr       Date:  2010-01

Review 3.  Coronary artery disease in women: From the yentl syndrome to contemporary treatment.

Authors:  Sofia Vaina; Anastasios Milkas; Christina Crysohoou; Christodoulos Stefanadis
Journal:  World J Cardiol       Date:  2015-01-26

4.  Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI.

Authors:  Gert Klug; Agnes Mayr; Johannes Mair; Michael Schocke; Michael Nocker; Thomas Trieb; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  Clin Res Cardiol       Date:  2011-01-04       Impact factor: 5.460

Review 5.  Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction.

Authors:  Matthew Liakos; Puja B Parikh
Journal:  Curr Cardiol Rep       Date:  2018-06-16       Impact factor: 2.931

6.  The prognosis of primary percutaneous coronary intervention after one year clinical follow up.

Authors:  Yahya Dadjoo; Yadallah Mahmoodi
Journal:  Int Cardiovasc Res J       Date:  2013-03-15

7.  Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.

Authors:  Dimitrios Venetsanos; Sofia Sederholm Lawesson; Joakim Alfredsson; Magnus Janzon; Angel Cequier; Mohamed Chettibi; Shaun G Goodman; Arnoud W Van't Hof; Gilles Montalescot; Eva Swahn
Journal:  BMJ Open       Date:  2017-09-21       Impact factor: 2.692

8.  Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.

Authors:  Petr Widimsky; William Wijns; Jean Fajadet; Mark de Belder; Jiri Knot; Lars Aaberge; George Andrikopoulos; Jose Antonio Baz; Amadeo Betriu; Marc Claeys; Nicholas Danchin; Slaveyko Djambazov; Paul Erne; Juha Hartikainen; Kurt Huber; Petr Kala; Milka Klinceva; Steen Dalby Kristensen; Peter Ludman; Josephina Mauri Ferre; Bela Merkely; Davor Milicic; Joao Morais; Marko Noc; Grzegorz Opolski; Miodrag Ostojic; Dragana Radovanovic; Stefano De Servi; Ulf Stenestrand; Martin Studencan; Marco Tubaro; Zorana Vasiljevic; Franz Weidinger; Adam Witkowski; Uwe Zeymer
Journal:  Eur Heart J       Date:  2009-11-19       Impact factor: 29.983

9.  Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center.

Authors:  Nicolas W Shammas; Gail A Shammas; Michael Jerin; Peter Sharis
Journal:  Vasc Health Risk Manag       Date:  2014-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.